Linda A. Fitzpatrick

Linda A. Fitzpatrick is a declared insider of Sutro Biopharma, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 1 October 2018 and 1 May 2025, the trades on record add up to 43 filings.

Every open-market trade on record is a purchase: 1 purchase worth €23k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 16 share grants and 23 option exercises.

The latest filing, published on 5 May 2025, reports an option exercise in Sutro Biopharma, Inc. The last insider purchase was made public on 14 May 2020, 2,353 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.